A Comparison of the Resection Rate for Hot and Cold Snare Polypectomy of Colorectal Polyps (10-15 Mm)
Launched by TECHNICAL UNIVERSITY OF MUNICH · Mar 23, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different methods for removing adenomatous polyps, which are growths in the colon that could lead to colorectal cancer. The two methods being studied are called hot snare polypectomy (HSP) and cold snare polypectomy (CSP). HSP uses heat to help remove the polyp but can sometimes lead to complications like bleeding. On the other hand, CSP does not use heat and is thought to be safer with fewer side effects. The researchers want to see which method is better at completely removing polyps that are between 10 and 15 millimeters in size.
To participate in this trial, you need to be scheduled for a colonoscopy and have at least one adenomatous polyp that is between 10 and 15 millimeters. You'll need to provide written consent to take part. If you have certain health conditions, such as severe heart problems or are on specific blood-thinning medications, you may not be eligible. Participants can expect to have their polyps removed using one of the two methods, and the study aims to improve our understanding of which method works best for these types of polyps.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indication for colonoscopy
- • at least 1 adenomatous polyp 10-15 mm
- • provided written informed consent
- Exclusion Criteria:
- • American Society of Anaesthesiologists class IV or higher
- • florid inflammatory bowel disease
- • emergency indication for colonoscopy
- • haemorrhagic diathesis
- • continued dual antiplatelet therapy
- • continued anticoagulant therapy
About Technical University Of Munich
The Technical University of Munich (TUM) is a leading research institution in Germany, renowned for its commitment to excellence in education, innovation, and technology transfer. With a strong emphasis on interdisciplinary collaboration, TUM fosters advancements in various fields, including medicine and life sciences. The university actively engages in clinical research, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Through its state-of-the-art facilities and a network of partnerships with hospitals and industry, TUM is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and contribute significantly to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
München, Bavaria, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials